Christopher L. Jordan

Statistics

Publications

Citations

639

H-Index

Active since

1993

Affiliations

Eli Lilly (United States)(Current)

Christopher L. Jordan is an author at Eli Lilly (United States) specializing in drug discovery, medicinal chemistry, and structure-activity relationships.

Publications per year

1993–1996

Publications

Phenethylthiazolethiourea (PETT) Compounds, a New Class of HIV-1 Reverse Transcriptase Inhibitors. 1. Synthesis and Basic Structure-Activity Relationship Studies of PETT Analogs

Frank W. Bell, Amanda Cantrell, Marita Hoegberg et al. · Journal of Medicinal Chemistry · 1995 · 455 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Phenethylthiazolylthiourea (PETT) Compounds as a New Class of HIV-1 Reverse Transcriptase Inhibitors. 2. Synthesis and Further Structure−Activity Relationship Studies of PETT Analogs

Amanda Cantrell, Per Engelhardt, Marita Högberg et al. · Journal of Medicinal Chemistry · 1996 · 112 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +17

Discovery and structure-activity relationship of a series of 1-carba-1-dethiacephems exhibiting activity against methicillin-resistant Staphylococcus aureus

Robert J. Ternansky, Susan E. Draheim, Andrew Pike et al. · Journal of Medicinal Chemistry · 1993 · 41 citations

Pharmacy, Medicinal Chemistry, Pharmacology +12

Stereoselective synthesis of cis-substituted azetidinones from penicillin: A formal total synthesis of loracarbef

Jack B. Deeter, David Hall, Christopher L. Jordan et al. · Tetrahedron Letters · 1993 · 21 citations

Natural Sciences, Chemistry, Medicinal Chemistry +11

Synthesis and anaerobic activity of novel 1-carba-1-dethiacephalosporins

R. J. TERNANSKY, Christopher L. Jordan, J S Kasher · Journal of Medicinal Chemistry · 1993 · 10 citations

Pharmacy, Medicinal Chemistry, Pharmacokinetics +17

1–5 of 5